PMID: 8967666Dec 1, 1996Paper

Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial

Annals of Internal Medicine
D WatersD Schade

Abstract

To increase lean body mass and improve health status in patients with wasting associated with the acquired immunodeficiency syndrome (AIDS) by treatment with recombinant human growth hormone (rhGH), recombinant human insulin-like growth factor 1 (rhIGF-1), or both. Randomized, double-blind, placebo-controlled clinical trial. University of New Mexico Clinical Research Center and University of Texas Southwestern Medical Center. 60 patients with AIDS and wasting as defined by the Centers for Disease Control and Prevention. Patients were divided into four groups of 15 patients each. Group 1 received 1.4 mg of rhGH once daily plus placebo twice daily; group 2 received 5 mg of rhIGF-1 twice daily plus placebo once daily; group 3 received 5 mg of rhIGF-1 twice daily plus 1.4 mg of rhGH once daily; and group 4 received placebo three times daily. Body weight, body composition, muscle strength, protein catabolism, quality of life, and immune status were assessed at baseline, and changes in these variables were measured at 6 and 12 weeks. At 6 weeks, lean body mass had increased and total fat mass had decreased in the groups receiving rhGH, rhIGF-1, or both. Group 3 had the greatest changes in lean body mass (mean +/- SE, 3.2 +/- 0.59 kg;...Continue Reading

Citations

Feb 22, 2000·JAMA : the Journal of the American Medical Association·S BhasinG Beall
Mar 19, 2003·Current Infectious Disease Reports·Benedito A. Carneiro-FilhoRichard L. Guerrant
Feb 5, 2004·Brain, Behavior, and Immunity·Keith W Kelley
Aug 4, 1998·The American Journal of Medicine·N A Tritos, C S Mantzoros
Aug 7, 2002·International Journal of Cardiology·Kathleen Mulligan, Morris Schambelan
Sep 27, 2001·Endocrinology and Metabolism Clinics of North America·S BhasinM Javanbakht
Oct 24, 1998·Nutrition·C S Ball
May 20, 1999·Baillière's Clinical Endocrinology and Metabolism·R Casaburi
Aug 14, 2003·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Anders Juul
Jun 3, 1999·The New England Journal of Medicine·C Corcoran, S Grinspoon
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·S E MulroneyM D Lumpkin
Dec 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E L MurphyS Krubel
Mar 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Judith NeradMarcy Fenton
Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Denise L JacobsonIra B Wilson
Aug 1, 1997·AIDS Patient Care and STDs·M Cianfrocca, J H Von Roenn
Sep 26, 1997·AIDS·G SakoulasP Hartzband
Oct 29, 1998·AIDS·F CarbonnelW Rozenbaum
Dec 24, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·J CofrancescoA S Dobs
Sep 2, 2006·HIV Medicine·W D DudgeonG A Hand
Dec 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Charles S FuchsMichael Pollak
May 12, 2005·Hormone Research·Robert J FerryLorraine E Levitt Katz
Jun 12, 2003·Sports Medicine·Richard J GodfreyGregory P Whyte
Nov 1, 2002·The Lancet Infectious Diseases·Anthony Kong, Polly Edmonds
Jul 9, 2014·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Anastassios Philippou, Elisabeth R Barton
Jun 15, 2011·Best Practice & Research. Clinical Endocrinology & Metabolism·Julian Falutz
Jul 10, 2007·Journal of the American Medical Directors Association·Shing-Shing YehMichael W Schuster
Mar 6, 2004·HIV Clinical Trials·Bruce PolskyCorklin Steinhart
Jan 22, 2002·Best Practice & Research. Clinical Endocrinology & Metabolism·P V Carroll
Oct 7, 2005·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Cristina CuerdaPilar García
Apr 30, 1998·The Annals of Pharmacotherapy·P A WindischK A Matuszewski
Apr 30, 1998·The Annals of Pharmacotherapy·D L BalogM I Amodio-Groton
Nov 26, 1999·JPEN. Journal of Parenteral and Enteral Nutrition·K MulliganM Schambelan
Dec 18, 2003·European Journal of Clinical Nutrition·V JirathitikalA S Bourinbaiar
Aug 31, 2004·World Journal of Gastroenterology : WJG·Shuang ChenQing-Jia Ou
Aug 13, 2004·European Journal of Clinical Investigation·O AndersenJ Iversen
Jul 11, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Caroline J ChantryUNKNOWN PACTG 1010 Team

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.